JPMorgan Chase & Co. (NYSE:JPM) Shares Bought by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. boosted its stake in JPMorgan Chase & Co. (NYSE:JPM - Free Report) by 2.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,542,509 shares of the financial services provider's stock after buying an additional 89,066 shares during the period. JPMorgan Chase & Co. accounts for approximately 1.6% of Robeco Institutional Asset Management B.V.'s investment portfolio, making the stock its 7th largest holding. Robeco Institutional Asset Management B.V. owned 0.13% of JPMorgan Chase & Co. worth $849,175,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Verus Wealth Management LLC bought a new position in JPMorgan Chase & Co. during the fourth quarter valued at about $334,000. Deane Retirement Strategies Inc. bought a new position in JPMorgan Chase & Co. during the fourth quarter valued at about $2,347,000. Foster Group Inc. boosted its stake in JPMorgan Chase & Co. by 1.2% during the fourth quarter. Foster Group Inc. now owns 6,367 shares of the financial services provider's stock valued at $1,526,000 after buying an additional 74 shares in the last quarter. Fulton Breakefield Broenniman LLC boosted its position in shares of JPMorgan Chase & Co. by 6.4% in the 4th quarter. Fulton Breakefield Broenniman LLC now owns 17,249 shares of the financial services provider's stock valued at $4,135,000 after purchasing an additional 1,035 shares during the period. Finally, Capital Investment Counsel LLC boosted its position in shares of JPMorgan Chase & Co. by 1.6% in the 4th quarter. Capital Investment Counsel LLC now owns 38,003 shares of the financial services provider's stock valued at $9,110,000 after purchasing an additional 586 shares during the period. 71.55% of the stock is owned by institutional investors and hedge funds.

JPMorgan Chase & Co. Trading Up 0.5 %

Shares of NYSE:JPM traded up $1.34 during midday trading on Tuesday, reaching $268.15. The company's stock had a trading volume of 5,619,778 shares, compared to its average volume of 10,176,410. The firm has a market capitalization of $754.93 billion, a price-to-earnings ratio of 13.58, a PEG ratio of 2.87 and a beta of 1.12. The company has a debt-to-equity ratio of 1.24, a quick ratio of 0.89 and a current ratio of 0.88. The firm has a 50 day moving average price of $248.25 and a two-hundred day moving average price of $228.90. JPMorgan Chase & Co. has a fifty-two week low of $172.62 and a fifty-two week high of $270.82.

JPMorgan Chase & Co. (NYSE:JPM - Get Free Report) last issued its quarterly earnings data on Wednesday, January 15th. The financial services provider reported $4.81 EPS for the quarter, topping the consensus estimate of $4.03 by $0.78. The firm had revenue of $42.77 billion during the quarter, compared to the consensus estimate of $41.90 billion. JPMorgan Chase & Co. had a return on equity of 16.99% and a net margin of 20.96%. The company's quarterly revenue was up 10.9% compared to the same quarter last year. During the same period in the prior year, the business posted $3.04 earnings per share. As a group, analysts forecast that JPMorgan Chase & Co. will post 17.82 earnings per share for the current year.

JPMorgan Chase & Co. Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Monday, January 6th were issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.86%. The ex-dividend date of this dividend was Monday, January 6th. JPMorgan Chase & Co.'s dividend payout ratio (DPR) is 25.33%.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Keefe, Bruyette & Woods boosted their price target on shares of JPMorgan Chase & Co. from $257.00 to $264.00 and gave the company a "market perform" rating in a report on Thursday, January 16th. UBS Group boosted their target price on JPMorgan Chase & Co. from $276.00 to $287.00 and gave the stock a "buy" rating in a report on Thursday, January 16th. Royal Bank of Canada boosted their target price on JPMorgan Chase & Co. from $211.00 to $230.00 and gave the stock an "outperform" rating in a report on Monday, October 14th. Oppenheimer lowered JPMorgan Chase & Co. from an "outperform" rating to a "market perform" rating in a report on Wednesday, November 20th. Finally, Wolfe Research upgraded JPMorgan Chase & Co. from a "peer perform" rating to an "outperform" rating and set a $269.00 target price for the company in a report on Friday, January 3rd. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and ten have issued a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $251.78.

Insider Transactions at JPMorgan Chase & Co.

In other JPMorgan Chase & Co. news, General Counsel Stacey Friedman sold 3,303 shares of the firm's stock in a transaction dated Thursday, January 16th. The stock was sold at an average price of $253.94, for a total transaction of $838,763.82. Following the sale, the general counsel now owns 47,620 shares in the company, valued at $12,092,622.80. This trade represents a 6.49 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.79% of the company's stock.

About JPMorgan Chase & Co.

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.